Georgea Foley

Publications
Public outreach and news

Articles

Journal article: CANCERS. 2025;18(1):79
Prostate Cancer Disparities Between Public and Private Healthcare Patients in Tasmania, a Regional State of Australia
Foley GR; Blizzard CL; Skala M; Redwig F; Roydhouse J; Dickinson JL; FitzGerald LM
Journal article: EUROPEAN UROLOGY. 2025;87:s1143
A0336 – Germline sequencing analysis to enhance clinical gene panel testing for clinically significant prostate cancer and biochemical recurrence following radical prostatectomy
Foley GR; Morales EU; Darst B; Saunders E; Dadaev T; Nordström T; Eklund M; Egevad L; Grönberg H; Plym A; Conti DV; Kote-Jarai Z; Haiman CA; Wiklund F
Article: CANCERS. 2024;16(13):2482
Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants
Foley GR; Marthick JR; Lucas SE; Raspin K; Banks A; Stanford JL; Ostrander EA; Fitzgerald LM; Dickinson JL
Article: SCIENTIFIC REPORTS. 2022;12(1):3022
Urban-rural prostate cancer disparities in a regional state of Australia
Foley GR; Blizzard CL; Stokes B; Skala M; Redwig F; Dickinson JL; FitzGerald LM
Article: INTERNATIONAL JOURNAL OF CANCER. 2021;149(5):1089-1099
A rare variant in EZH2 is associated with prostate cancer risk
Raspin K; FitzGerald LM; Marthick JR; Field MA; Malley RC; Banks A; Donovan S; Thomson RJ; Foley GR; Stanford JL; Dickinson JL

All other publications

Conference publication: EUROPEAN UROLOGY. 2026;89
Refining prostate cancer screening with family history: 10-year results from the STHLM3 screening trial
Mariaz M; Micoli C; Foley G; Discacciati A; Palm EE; Morales EU; Kibel AS; Nordstrom T; Eklund M; Gronberg H; Clements M; Lant A; Wiklund F; Plym A
Conference publication: EUROPEAN UROLOGY. 2025;87
Risk of clinically significant prostate cancer by polygenic risk score, family history, and prostate-specific antigen: 8-year findings from the prospective STHLM3 study
Mariaz M; Morales EU; Foley G; Discacciati A; Kibel AS; Nordstrom T; Eklund M; Lantz A; Clements M; Gronberg H; Wiklund F; Plym A
Conference publication: EUROPEAN UROLOGY. 2025;87
Germline sequencing analysis to enhance clinical gene panel testing for clinically significant prostate cancer and biochemical recurrence following radical prostatectomy
Foley GR; Morales EU; Darst B; Saunders E; Dadaev T; Nordstrom T; Eklund M; Egevad L; Gronberg H; Plym A; Conti DV; Kote-Jarai Z; Haiman CA; Wiklund F
Letter: EUROPEAN JOURNAL OF CANCER. 2023;180:155-157
Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing
Foley GR; Marthick JR; Ostrander EA; Stanford JL; Dickinson JL; FitzGerald LM
Letter: EUROPEAN UROLOGY. 2022;82(6):e169
Re: Daniel J. Lee, Ryan Hausler, Anh N. Le, et al. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Eur Urol 2022;81:559-67 Red Flags in Association Analyses for Rare Variants
Dickinson JL; Foley GR; FitzGerald LM
Preprint: MEDRXIV. 2022
Germline sequencing of DNA-damage-repair genes in two hereditary prostate cancer cohorts reveals new disease risk-associated gene variants
Foley GR; Marthick JR; Lucas SE; Raspin K; Banks A; Stanford JL; Ostrander EA; FitzGerald LM; Dickinson JL
Letter: EUROPEAN JOURNAL OF CANCER. 2021;159:52-55
Massively parallel sequencing in hereditary prostate cancer families reveals a rare risk variant in the DNA repair gene, RAD51C
Marthick JR; Raspin K; Foley GR; Blackburn NB; Banks A; Donovan S; Malley RC; Field MA; Stanford JL; Ostrander EA; FitzGerald LM; Dickinson JL

Articles

All other publications

News from KI

Events from KI